345 results on '"Carboplatin -- Intellectual property"'
Search Results
2. Patent Application Titled 'Fatty Acid Synthase Inhibitors' Published Online (USPTO 20210338676)
3. Researchers Submit Patent Application, 'Anti-Cancer Activity Of Adamantane Derivatives', for Approval (USPTO 20210330605)
4. Patent Issued for Polymorphic forms of RAD1901-2HCL (USPTO 11148996)
5. Patent Application Titled 'Antibodies Having Specificity To Nectin-4 And Uses Thereof' Published Online (USPTO 20210324104)
6. Patent Application Titled 'Biomarkers For Sacituzumab Govitecan Therapy' Published Online (USPTO 20210316003)
7. 'Kinase Activity In Tumors' in Patent Application Approval Process (USPTO 20210318318)
8. Patent Issued for Amino-triazolopyridine compounds and their use in treating cancer (USPTO 11136340)
9. Patent Application Titled 'Prognostic And Predictive Transcriptomic Signatures For Uterine Serous Carcinomas' Published Online (USPTO 20210310074)
10. Patent Application Titled 'Pharmaceutical Composition For Preventing Or Treating Sensorineural Hearing Loss, Containing Forskolin And Retinoic Acid As Active Ingredients' Published Online (USPTO 20210299084)
11. Patent Issued for Compounds useful as inhibitors of ATR kinase and combination therapies thereof (USPTO 11110086)
12. Patent Issued for Compounds for treatment of cancer (USPTO 11084811)
13. Researchers Submit Patent Application, 'Otic Formulations For Drug-Induced Ototoxicity', for Approval (USPTO 20210186943)
14. 'Anti-Tissue Factor Antibody-Drug Conjugates And Their Use In The Treatment Of Cancer' in Patent Application Approval Process (USPTO 20210177987)
15. Patent Application Titled 'Cavitation-Enhanced Targeted Drug Delivery And Dosing' Published Online (USPTO 20210146157)
16. 'Ultrasound Frequency And Microbubble Size Optimization In Microbubble-Enhanced Ultrasound Treatment' in Patent Application Approval Process (USPTO 20210146156)
17. Researchers Submit Patent Application, 'Bi-Specific Antibodies And Uses Thereof', for Approval (USPTO 20210154319)
18. Patent Application Titled 'Combination Therapy' Published Online (USPTO 20210155903)
19. Patent Issued for 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic (USPTO 10993920)
20. Immutep granted Chinese patent for eftilagimod alpha
21. Patent Issued for 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione As A Cancer Therapeutic (USPTO 10,993,920)
22. Patent Issued for GLA Monotherapy For Use In Cancer Treatment (USPTO 10,993,956)
23. Researchers Submit Patent Application, 'Drug Delivery System', for Approval (USPTO 20210113468)
24. Patent Issued for De-Epoxidized Epothilone Derivative Preparation, Preparation Of Same And Use Thereof In The Treatment Of Tumor (USPTO 10,980,782)
25. 'Herpes Simplex Virus (Hsv) Anticancer Therapies' in Patent Application Approval Process (USPTO 20210100859)
26. Patent Issued for Stable Pharmaceutical Formulations Of Pemetrexed (USPTO 10,966,982)
27. Patent Application Titled 'Combined Local Delivery Of Therapeutic Agents Using Interventional Devices And Radiation' Published Online (USPTO 20210086000)
28. Researchers Submit Patent Application, 'Methylation-Based Biomarkers In Breast Cancer Screening, Diagnosis, Or Prognosis', for Approval (USPTO 20210079482)
29. Researchers Submit Patent Application, 'Treatment Of Advanced Estrogen Receptor Positive Breast Cancer', for Approval (USPTO 20210046084)
30. Researchers Submit Patent Application, 'Treatment Of Cancer By Systemic Administration Of Dbait Molecules', for Approval (USPTO 20210023116)
31. Patent Issued for Cytotoxic Agents For The Treatment Of Cancer (USPTO 10,881,678)
32. Patent Application Titled 'Antitumor Agent, Antitumor Effect Enhancer, And Antitumor Kit' Published Online (USPTO 20200405752)
33. 'Administration Of Aurora Kinase Inhibitor And Chemotherapeutic Agents' in Patent Application Approval Process (USPTO 20200397799)
34. 'Antibodies To Human B7x For Treatment Of Metastatic Cancer' in Patent Application Approval Process (USPTO 20200392246)
35. 'Anti-Mesothelin Immunoconjugates And Uses Therefor' in Patent Application Approval Process (USPTO 20200377614)
36. Patent Application Titled 'Demethylpenclomedine Analogs And Their Use As Anti-Cancer Agents' Published Online (USPTO 20200375964)
37. Patent Application Titled 'Curcuphenol Compounds For Increasing Mhc-I Expression' Published Online (USPTO 20200375917)
38. 'Novel Anti-Tumor Compound And Application Thereof In Preparing Anti-Tumor Drugs' in Patent Application Approval Process (USPTO 20200377545)
39. Patent Issued for Non-Hydrophobic Compounds For Use In Treating Metastasis And/Or Cartilage Defect (USPTO 10,828,281)
40. Patent Issued for Treatment Of Cancer By Systemic Administration Of Dbait Molecules (USPTO 10,821,128)
41. 'Pdl1 Peptides For Use In Cancer Vaccines' in Patent Application Approval Process (USPTO 20200339659)
42. Patent Issued for Combination Therapies Using HDAC Inhibitors (USPTO 10,799,469)
43. Researchers Submit Patent Application, 'Polypeptides And Uses Thereof For The Treatment Of Cancer', for Approval (USPTO 20200299341)
44. Patent Issued for Anti-Mesothelin Immunoconjugates And Uses Therefor (USPTO 10,781,263)
45. 'Carbon Dot Liposomes And Uses Thereof' in Patent Application Approval Process (USPTO 20200289425)
46. 'Use Of Benzofuran Lignans To Induce Il-25 Expression And Suppress Mammary Tumor Metastasis' in Patent Application Approval Process (USPTO 20200289454)
47. Researchers Submit Patent Application, 'Fabrication And Application Of A Hetero-Targeted Nano-Cocktail With Traceless Linkers', for Approval (USPTO 20200281955)
48. Patent Issued for Pharmaceutical Composition For Preventing Or Treating Cancer (USPTO 10,751,352)
49. Patent Issued for Curcuphenol Compounds For Increasing MHC-I Expression (USPTO 10,751,296)
50. Patent Application Titled 'Tinostamustine For Use In Treating Ovarian Cancer' Published Online (USPTO 20200261423)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.